Myriam Curet Sells 230 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 230 shares of the business’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $532.61, for a total value of $122,500.30. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60.
• On Monday, November 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The shares were sold at an average price of $560.00, for a total transaction of $58,800.00.

Intuitive Surgical Price Performance

ISRG opened at $507.55 on Friday. The company has a 50 day simple moving average of $559.78 and a two-hundred day simple moving average of $511.72. The firm has a market cap of $181.95 billion, a P/E ratio of 64.33, a PEG ratio of 4.05 and a beta of 1.67. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the company earned $2.21 EPS. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Institutional Investors Weigh In On Intuitive Surgical

Several large investors have recently bought and sold shares of the business. SteelPeak Wealth LLC increased its position in shares of Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after acquiring an additional 9,364 shares during the period. Amalgamated Bank grew its stake in Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after purchasing an additional 1,772 shares in the last quarter. Bessemer Group Inc. increased its holdings in Intuitive Surgical by 89.3% during the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after purchasing an additional 371,806 shares during the period. Sax Wealth Advisors LLC raised its position in Intuitive Surgical by 218.1% during the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after purchasing an additional 1,684 shares in the last quarter. Finally, World Investment Advisors raised its position in Intuitive Surgical by 238.3% during the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock valued at $2,415,000 after purchasing an additional 3,803 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on ISRG shares. Royal Bank Of Canada lifted their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Sanford C. Bernstein increased their price objective on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Daiwa Capital Markets lifted their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $620.41.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands the da Vinci 5 indication set into select advanced cardiac procedures — large addressable?market implication and a long?term revenue tail for systems and consumables. Read More.
• Positive Sentiment: TD Cowen initiated/raised coverage to a strong?buy, which can attract institutional demand and support near?term buying interest. Read More.
• Positive Sentiment: Major sell?side support continues (Barclays reaffirmed buy) and HSBC issued a bullish price?appreciation forecast — both reinforce positive analyst momentum around growth prospects. Read More. Read More.
• Positive Sentiment: Active managers (Polen Capital) are highlighting ISRG as a core growth holding, signaling conviction from long?term growth investors. Read More.
• Neutral Sentiment: Analysts are split on valuation — some price?target trims (e.g., Evercore ISI) coexist with higher targets from other firms; that creates mixed guidance for short?term price direction. Read More.
• Neutral Sentiment: Coverage pieces questioning whether to “reassess” ISRG after recent share weakness may drive flows from momentum or value?oriented investors, but they’re not direct catalysts. Read More.
• Negative Sentiment: Significant insider selling by director Gary S. Guthart (24,500 shares + 2,800 shares disclosed) — large, disclosed sales can trigger profit?taking and amplify downward pressure on the stock near term. Read More.
• Negative Sentiment: EVP Myriam Curet sold 230 shares (smaller amount) — adds to the day’s insider activity and can increase negative sentiment despite being immaterial in size. Read More.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.